Leveraging implementation science to enhance the adoption of DPYD testing

Pharmacogenet Genomics. 2026 Mar 1;36(2):80-82. doi: 10.1097/FPC.0000000000000581. Epub 2025 Dec 16.

Sony Tuteja¹, J Kevin Hicks², Larisa H Cavallari³, Nihal El Rouby^{4

5}, D Max Smith^{6

7}, Jai N Patel^{8

9}, Daniel L Hertz¹⁰

¹ Division of Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Department of Pathology, Moffitt Cancer Center, Tampa.
³ Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida.
⁴ Department of Pharmacy Practice and Administrative Sciences, Division of Pharmacy Practice & Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio.
⁵ Precision Medicine Department, St. Elizabeth Healthcare, Edgewood, Kentucky.
⁶ Department of Genetic Medicine, MedStar Health, Columbia, Maryland.
⁷ Department of Oncology, Georgetown University Medical Center, Washington, District of Columbia.
⁸ Division of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer, Charlotte.
⁹ Department of Cancer Biology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.
¹⁰ Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.

No abstract available